We have previously shown that intra-tumoral IL-2 combined with anti-CD40 antibody leads to AE17 mesothelioma tumor regression in young mice; this was associated with increased CTL activity (Jackaman et al., 2008, 2016). Here, CD40 is linked to mesothelioma.